Table 1.

Patient characteristics

Age (y)
    Median70.5
    Range56-79
Race
    Caucasian12 (86%)
    Hispanic2 (14%)
Prostatic acid phosphatase (units/L)
    Median2.7
    Range1-25
PSA (ng/mL)
    Median84.6
    Range8-725
Alkaline phosphatase (units/L)
    Median113.5
    Range53-840
Lactate dehydrogenase (units/L)
    Median165
    Range113-441
Hemoglobin (g/dL)
    Median12.65
    Range9.3-14.5
Karnofsky performance status, n (%)
    703 (21%)
    801 (7%)
    909 (64%)
    1001 (7%)
Extent of disease, n (%)
    Bone disease14 (100%)
    Bone and soft tissue4 (28%)
Prior systemic therapy, n (%)
    Androgen deprivation14 (100%)
    Chemotherapy7 (50%)
    Immunotherapy2 (14%)
    Other investigational treatment1 (7%)